Early experience of percutaneous paravalvular leak closure using a novel Occlutech occluder

Basit Öğe Kaydı
dc.contributor.authorGöktekin, Ömer
dc.contributor.authorVatankulu, Mehmet Akif
dc.contributor.authorÖzhan, Hakan
dc.contributor.authorAy, Yasin
dc.contributor.authorErgelen, Mehmet
dc.contributor.authorTasal, Abdurrahman
dc.contributor.authorHijazi, Ziyad
dc.date.accessioned2020-05-01T09:11:32Z
dc.date.available2020-05-01T09:11:32Z
dc.date.issued2016
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.descriptionWOS: 000372767000020en_US
dc.descriptionPubMed: 26897292en_US
dc.description.abstractAims: Paravalvular regurgitation is an important complication of mitral valve replacement. Although surgical repair is mostly recommended, it is associated with significant morbidity. On the other hand, percutaneous closure is a less invasive alternative approach. Percutaneous approaches to treatment of paravalvular prosthetic regurgitation have emerged recently. One of them is the Occlutech Paravalvular Leak Device. The aim of this study was to evaluate early and midterm outcomes of percutaneous paravalvular leak closure utilising a novel occluder. Methods and results: Twenty-one consecutive symptomatic patients who had moderate or severe paravalvular prosthetic regurgitation on transoesophageal echocardiography were included in the study. All the patients were clinically evaluated and found inoperable for surgery. They underwent transapical repair with the Occlutech Paravalvular Leak Device. The patients were followed for 17 +/- 5 months. Attempts were made to rectify 41 defects in 21 patients with 100% success. Mean procedure time was 76140 min and fluoroscopy time was 44 +/- 37 min. Early post-procedural outcome was uneventful in all cases, with >= 1 grade reduction in regurgitation in all of the patients. There was no mortality during hospital stay. There was one case of haemothorax in one patient and one case of pneumothorax in another. Post-implantation 90-day follow-up data were obtained for 19 patients, and 12-month data were obtained for 12 patients. No deaths due to any cause, stroke or surgery for prosthetic impingement, worsening or relapse of paravalvular leak during follow-up were recorded. One patient underwent reintervention and was treated successfully with the same occluder 11 months after the index procedure. Conclusions: The novel Occlutech Paravalvular Leak Device, which was designed specifically for mitral and aortic paravalvular regurgitation, is an additional, useful tool in the device armamentarium for the treatment of PVL.en_US
dc.identifier.doi10.4244/EIJV11I10A237en_US
dc.identifier.endpage1200en_US
dc.identifier.issn1774-024X
dc.identifier.issn1969-6213
dc.identifier.issue10en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage1195en_US
dc.identifier.urihttps://doi.org/10.4244/EIJV11I10A237
dc.identifier.urihttps://hdl.handle.net/20.500.12684/5648
dc.identifier.volume11en_US
dc.identifier.wosWOS:000372767000020en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherEuropa Editionen_US
dc.relation.ispartofEurointerventionen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectaortic valve diseaseen_US
dc.subjectmitral valve diseaseen_US
dc.subjectvalvular heart diseaseen_US
dc.titleEarly experience of percutaneous paravalvular leak closure using a novel Occlutech occluderen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
5648.pdf
Boyut:
1.98 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu